1,153
Views
13
CrossRef citations to date
0
Altmetric
Original Research

T-helper cell receptors from long-term survivors after telomerase cancer vaccination for use in adoptive cell therapy

, , , , , , , , & show all
Article: e1249090 | Received 27 Jun 2016, Accepted 12 Oct 2016, Published online: 05 Dec 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (12)

Carole Beck, Nicholas Paul Casey, Irene Persiconi, Neda Nejati Moharrami, Adam Sike, Yixin Jin & Jon Amund Kyte. (2023) Development of a TGFβ—IL-2/15 Switch Receptor for Use in Adoptive Cell Therapy. Biomedicines 11:2, pages 459.
Crossref
Dimitrios Bafaloukos, Kalliopi Petraki, Aikaterini Bousmpoukea, Eleni Chatzichristou, Ioannis Pieris, Christos Koutserimpas & George Samonis. (2022) Therapeutic Effect of mRNA SARS-CoV-2 Vaccine on Melanoma Skin Metastases. Vaccines 10:4, pages 525.
Crossref
Jon Amund Kyte. (2022) Strategies for Improving the Efficacy of CAR T Cells in Solid Cancers. Cancers 14:3, pages 571.
Crossref
Anqi Lin, Hongman Zhang, Hui Meng, Ze Deng, Tianqi Gu, Peng Luo & Jian Zhang. (2021) TNF-Alpha Pathway Alternation Predicts Survival of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer. Frontiers in Immunology 12.
Crossref
Robert H Vonderheide, Kimberly A Kraynyak, Anthony F Shields, Autumn J McRee, Jennifer M Johnson, Weijing Sun, Ashish V Chintakuntlawar, Jan Pawlicki, Albert J Sylvester, Trevor McMullan, Robert Samuels, Joseph J Kim, David Weiner, Jean D Boyer, Matthew P Morrow, Laurent Humeau & Jeffrey M Skolnik. (2021) Phase 1 study of safety, tolerability and immunogenicity of the human telomerase (hTERT)-encoded DNA plasmids INO-1400 and INO-1401 with or without IL-12 DNA plasmid INO-9012 in adult patients with solid tumors. Journal for ImmunoTherapy of Cancer 9:7, pages e003019.
Crossref
Pierre Dillard, Hakan Köksal, Solrun Melkorka Maggadottir, Anna Winge-Main, Sylvie Pollmann, Mathilde Menard, Marit Renée Myhre, Gunhild M. Mælandsmo, Vivi Ann Flørenes, Gustav Gaudernack, Gunnar Kvalheim, Sébastien Wälchli & Else Marit Inderberg. (2021) Targeting Telomerase with an HLA Class II-Restricted TCR for Cancer Immunotherapy. Molecular Therapy 29:3, pages 1199-1213.
Crossref
Simone Negrini, Raffaele De Palma & Gilberto Filaci. (2020) Anti-Cancer Immunotherapies Targeting Telomerase. Cancers 12:8, pages 2260.
Crossref
Stina George Fernandes, Rebecca Dsouza, Gouri Pandya, Anuradha Kirtonia, Vinay Tergaonkar, Sook Y. Lee, Manoj Garg & Ekta Khattar. (2020) Role of Telomeres and Telomeric Proteins in Human Malignancies and Their Therapeutic Potential. Cancers 12:7, pages 1901.
Crossref
Alan Chen Chen, Renhuan Xu, Tao Wang, Junping Wei, Xiao-Yi Yang, Cong-Xiao Liu, Gangjun Lei, Herbert Kim Lyerly, Teri Heiland & Zachary Conrad Hartman. (2020) HER2-LAMP vaccines effectively traffic to endolysosomal compartments and generate enhanced polyfunctional T cell responses that induce complete tumor regression. Journal for ImmunoTherapy of Cancer 8:1, pages e000258.
Crossref
Thomas W. Smith & Michael I. Nishimura. 2020. Current Immunotherapeutic Strategies in Cancer. Current Immunotherapeutic Strategies in Cancer 129 151 .
Eishiro Mizukoshi & Shuichi Kaneko. (2019) Telomerase-Targeted Cancer Immunotherapy. International Journal of Molecular Sciences 20:8, pages 1823.
Crossref
Patricia Mercier-LetondalChrystel MartonMarina DeschampsChristophe FerrandCharline VauchyClément ChenutAurélie BaguetOlivier AdotéviChristophe BorgJeanne GalaineYann Godet. (2018) Isolation and Characterization of an HLA-DRB1*04-Restricted HPV16-E7 T Cell Receptor for Cancer Immunotherapy. Human Gene Therapy 29:10, pages 1202-1212.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.